BPA Call HT001419A0039-HT001424F0138
Award Date
9/25/24
Potential Completion Date
9/30/24
Potential Value
$250K
Federal Agency
Defense Health Agency
Awardee
Broughton Pharmaceuticals, LLC
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Broughton Pharmaceuticals, LLC is for the delivery of emergency blood-related products used in patient care. The contract has a ceiling value of $89,584.24 and was awarded by the Defense Health Agency (DHA), a defense agency. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type, and an ultimate completion date of July 16, 2020. The contract does not utilize any set-aside designations. Broughton Pharmaceuticals is a for-profit...
This is a firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company. The $500,000.00 contract is for the provision of various pharmaceutical shortage items, including blood products, oncology pharmaceuticals, and other injectable, oral, and inhalation medications. The contract has no set-aside designation and was awarded on August 28, 2017 with a completion date of September...
The U.S. Department of Defense's Bureau of Medicine and Surgery awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The $150,000 contract is for the delivery of pharmaceutical products, including medications like RYDAPT, Novolog insulin, Carimune, and oncological drugs, as well as personal protective equipment such as N95 masks and disinfectant wipes. This BPA call is part of a...
This federal contract award, valued at $862,270.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that is not set-aside, indicating open competition. It covers a wide range of pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and specialized supplies. The contract is...
This federal contract award, valued at $765,884.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed-price pricing type, and a performance period ending on April 17, 2023. The contract is not set-aside and allows Amerisourcebergen Drug Corp to supply a variety of pharmaceutical products and medical supplies, including medications across...
This federal contract award, valued at $809,462.82, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating open competition. The contract provides for the delivery of a diverse range of pharmaceutical products and medical supplies, including prescription...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,494.00 contract is for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and specialty pharmaceuticals. The award is not set aside and is part of a larger $999,999,999.00 Indefinite...
This federal contract award, valued at $46,304.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, without any set-aside designation, indicating open competition. The contract provides for the delivery of a range of pharmaceutical and medical products, including medications across various therapeutic areas such as diabetes, neurology,...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a self-certified small disadvantaged business, to provide pharmaceutical supplies and drugs for the Walter Reed National Military Medical Center (WRNMMC). The $300,000 contract has an ultimate completion date of September 30, 2015 and was awarded on June 30, 2015. TDS Med, Inc. is an active federal contractor that has previously supported COVID-19 response...
This federal contract award, valued at $763,821.99, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and it has no set-aside designation, indicating open competition. The contract covers the delivery of a diverse range of pharmaceutical products and medical supplies, including prescription medications, medical...